Phio Pharmaceuticals Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Phio Pharmaceuticals Corp. generated cash of -$10,749,000, which is more than the previous year. Cash used in financing activities reached the amount of $7,413,000 last year. Net change in cash is therefore -$3,341,000.
Cash Flow
| 2014 | -7.75M | 2.91M | 1.94M |
|---|---|---|---|
| 2015 | -7.31M | -5.55M | 9.49M |
| 2016 | -7.76M | 5.34M | 10.20M |
| 2017 | -9.51M | -103K | 292K |
| 2018 | -7.52M | -5K | 18.82M |
| 2019 | -8.64M | -72K | 772K |
| 2020 | -8.80M | -19K | 16.13M |
| 2021 | -11.85M | -51K | 21.72M |
| 2022 | -12.12M | -121K | -26K |
| 2023 | -10.74M | -5K | 7.41M |
PHIOW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.83M | 24.10M | 14.29M | 6.98M | 14.92M | 3.63M | 12.95M | 5.11M | 8.49M | 11.39M |
Operating activities | ||||||||||
Net income | -10.82M | -11.48M | -13.28M | -8.79M | -8.90M | -7.36M | -12.45M | -8.99M | -10.22M | -8.8M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 184K | 193K | 75K | 72K | 67K | 81K | 70K | 53K | 77K | 87K |
Stock-based compensation expense | 303K | 414K | 480K | 136K | 300K | 282K | 314K | 756K | 1.53M | 1.84M |
| Deferred income tax benefit | 303K | 414K | 480K | 136K | 300K | 282K | 314K | 756K | 1.53M | 1.84M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -122K | 496K | -445K | -81K | 259K | 39K | -608K | -246K | 878K | 122K |
Cash generated by operating activities | -10.74M | -12.12M | -11.85M | -8.80M | -8.64M | -7.52M | -9.51M | -7.76M | -7.31M | -7.75M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2M | -8M | -5M |
Investments In Property Plant And Equipment | -5K | -121K | -51K | -19K | -72K | -5K | -203K | -4K | -57K | -95K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 0 | 0 | 0 |
Cash generated by investing activities | -5K | -121K | -51K | -19K | -72K | -5K | -103K | 5.34M | -5.55M | 2.91M |
Financing activities | ||||||||||
Common Stock Issued | 7.45M | 2K | 19.57M | 12.08M | 709K | 18.71M | 292K | 10.20M | 9.49M | 1.94M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -209K | 0 |
Repurchases of common stock | -13K | -28 | -1 | -15K | 0 | 3K | 0 | 0 | 0 | 61K |
Repayments of term debt | 0 | 0 | 0 | -27K | -6K | 0 | 0 | 0 | 0 | -61K |
Cash used in financing activities | 7.41M | -26K | 21.72M | 16.13M | 772K | 18.82M | 292K | 10.20M | 9.49M | 1.94M |
Net Change In Cash | -3.34M | -12.27M | 9.81M | 7.31M | -7.94M | 11.29M | -9.32M | 7.78M | -3.37M | -2.89M |
Cash at end of period | 8.49M | 11.83M | 24.10M | 14.29M | 6.98M | 14.92M | 3.63M | 12.90M | 5.11M | 8.49M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |